Caroline Robo

Caroline Robo (Fesquet) is an accomplished regulatory affairs professional with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director and Global Regulatory Lead at Alexion Pharmaceuticals, Inc. since July 2024, Caroline manages a team following the acquisition of Amolyt Pharma. Previously, as Director of Regulatory Affairs at Amolyt Pharma, Caroline led a team in defining strategic regulatory pathways from early phases to NDA/MAA. Prior roles include Director of Regulatory Affairs at Blue Reg Pharma Consulting, where Caroline led the European Regulatory Affairs team, and Senior Regulatory Affairs Project Manager at Galderma, overseeing global regulatory strategies for various projects. Caroline also worked as a Senior Regulatory Affairs Consultant at EUDRAC FRANCE, providing regulatory strategies for medicinal products. Caroline holds a Pharm.D. from the University of Montpellier and a DESS in EU Regulatory Affairs from the University of Lille 1 Sciences and Technology.